Hydrofarm Holdings Group's Q3 2025 results showed a 33% drop in sales due to continued industry oversupply, leading to wider net losses. Despite lower manufacturing volumes and reduced gross margins, the company achieved improvements in SG&A efficiencies and free cash flow while pursuing additional restructuring savings.

Hydrofarm's Q2 2025 revenue dropped to $39.2 million due to industry headwinds and reduced demand for durable products. The company narrowed its net loss and delivered $1.4 million in free cash flow. Strategic cost-cutting and restructuring efforts continued to improve operational efficiency as Hydrofarm reaffirmed its full-year guidance.

Hydrofarm Holdings Group reported a challenging first quarter in 2025 with net sales decreasing to $40.5 million from $54.2 million in the prior year. The company experienced an increased net loss of $14.4 million, compared to $12.6 million in the same period last year. Despite these declines, the company achieved sequential improvements by focusing on higher-margin proprietary brands and implementing cost-saving initiatives.

Hydrofarm reported Q4 2024 revenue of $37.3 million, a 20.9% decline year-over-year due to weaker demand in the cannabis industry. Net loss widened to $17.5 million, driven by lower sales and higher inventory reserves. Adjusted EBITDA fell to -$7.3 million, reflecting a challenging operating environment. The company maintained positive free cash flow of $2.4 million, supported by cost-cutting initiatives.

Hydrofarm Holdings Group reported a decrease in net sales to $44.0 million compared to $54.2 million in the prior year period. However, the company saw an increase in gross profit margin to 19.4% from 6.1% and an improvement in net loss to $13.1 million from $19.9 million. The company reaffirms its full year 2024 outlook on key metrics.

Hydrofarm Holdings Group reported a decrease in net sales to $54.8 million, but delivered positive Adjusted EBITDA for the fourth time in the last five quarters. The company is reaffirming its full year 2024 outlook on its key metrics.

Hydrofarm Holdings Group reported a decrease in net sales to $54.2 million compared to $62.2 million in the prior year period. However, the company saw improvements in gross profit margin, net loss, and adjusted EBITDA. The company is reiterating its 2024 guidance of positive Adjusted EBITDA and positive Free Cash Flow.

Hydrofarm's Q4 2023 results showed a decrease in net sales to $47.2 million, but an improvement in gross profit to $8.4 million and a reduced net loss of $(15.2) million. Adjusted EBITDA also improved to $(0.6) million. The company's restructuring plan and cost-saving efforts contributed to positive Adjusted EBITDA and Free Cash Flow for the full year 2023.

Hydrofarm Holdings Group reported a decrease in net sales to $54.2 million compared to $74.2 million in the third quarter of 2022. However, the company achieved positive adjusted EBITDA of $0.5 million, and improved its adjusted gross profit margin. They also initiated a second phase of restructuring to further improve efficiency and reduce costs.

Hydrofarm Holdings Group reported a decrease in net sales to $62.2 million, driven by a decline in volume and price/mix of products sold. Despite the sales decrease, the gross profit margin increased to 18.3%, and the company's net loss improved to $(16.8) million. The company reaffirms its full year 2023 outlook, expecting net sales between $290 million and $310 million and positive Free Cash Flow.

Hydrofarm Holdings Group reported a decrease in net sales to $61.5 million compared to $110.4 million in the prior year period. The company experienced a net loss of $(35.3) million, driven by decreased sales and restructuring costs. However, the company generated positive Free Cash Flow of $5.4 million and initiated a restructuring plan to improve cost savings.

Hydrofarm Holdings Group reported a decrease in net sales to $74.2 million compared to $123.8 million in the prior year period. The company experienced a net loss of $(23.5) million, or $(0.52) per diluted share, compared to net income of $17.3 million, or $0.37 per diluted share in the third quarter of 2021. They generated positive Free Cash Flow of $5.6 million. The company reaffirmed its full year 2022 outlook for net sales and adjusted EBITDA.

Hydrofarm Holdings Group reported a decrease in net sales and gross profit for the second quarter of 2022, driven by an industry recession and inventory reserves. The company experienced a net loss, including a significant non-cash goodwill impairment charge. Despite these challenges, Hydrofarm is taking steps to lower costs and maintain liquidity.

Hydrofarm Holdings Group reported flat net sales and a net loss for the first quarter of 2022, impacted by agricultural oversupply and increased expenses related to acquisitions and distribution center relocation. The company updated its full-year outlook with net sales expected between $480 million and $520 million and adjusted EBITDA between $46 million and $54 million.

Hydrofarm Holdings Group reported a 28.1% increase in net sales, a 64.9% increase in gross profit, and a significant increase in net income attributable to common stockholders. Adjusted EBITDA also saw a substantial increase. The company reaffirmed its updated full-year 2021 outlook.

Hydrofarm Holdings Group reported a strong second quarter in 2021, with net sales increasing by 46.7% to $133.8 million and adjusted EBITDA more than doubling to $16.2 million. The company completed two acquisitions during the quarter and revised its full-year outlook upward, anticipating continued growth and profitability.

Hydrofarm Holdings Group reported a strong start to 2021 with net sales increasing by 66.5% to $111.4 million and a significant rise in adjusted EBITDA to $9.9 million. The company also completed a follow-on equity offering, raising approximately $309.8 million, and acquired branded nutrient manufacturer, HEAVY 16.

Hydrofarm Holdings Group reported a strong fourth quarter in 2020, with net sales increasing by 62.6% compared to the prior year, driven by volume and price/mix improvements. Gross profit also saw significant growth, and Adjusted EBITDA improved substantially. The company successfully completed its IPO during the quarter.